Concepedia

Recent advances and application of ruthenium complexes in tumor malignancy

Rahul Kanaoujiya, Meenakshi, Shekhar Srivastava, Rasmeet Singh, Ghulam Mustafa

Materials Today Proceedings · 2022 · 45 citations · 46 references

DOI

Concepts

References

46

mTOR Inhibition Induces Upstream Receptor Tyrosine Kinase Signaling and Activates Akt

Kathryn O’Reilly, F. Rojo, Qing‐Bai She et al. · Cancer Research · 2006 · 2.6K citations · Full text

, , +16

Activin receptor-like kinase 1 modulates transforming growth factor-β1 signaling in the regulation of angiogenesis

S. Paul Oh, Tsugio Seki, Kendrick A. Goss et al. · Proceedings of the National Academy of Sciences · 2000 · 861 citations

, , +17

NKP-1339, the first ruthenium-based anticancer drug on the edge to clinical application

Robert Trondl, Petra Heffeter, Christian R. Kowol et al. · Chemical Science · 2014 · 659 citations · Full text

, , +14

Regulation of Telomerase Activity in Immortal Cell Lines

Shawn E. Holt, Woodring E. Wright, Jerry W. Shay · Molecular and Cellular Biology · 1996 · 365 citations · Full text

, , +16

Ligand substitutions between ruthenium–cymene compounds can control protein versus DNA targeting and anticancer activity

Zenita Adhireksan, Gabriela E. Davey, Pablo Campomanes et al. · Nature Communications · 2014 · 296 citations · Full text

, , +16